Patient factors | % (n) | Cancer and treatment factors | % (n) |
---|---|---|---|
Age [mean (min–max)] | 52.49 (32–77) | Time (months) since AET initiation | 24.38 (1–58) |
Marital status | Between 1 and 24 months | 49 (51) | |
Married | 75.9 (79) | Between 25 and 58 months | 51 (53) |
Singlea | 24 (25) | Current treatment | |
Children | Tamoxifenb | 47.1 (49) | |
One or more | 82.7 (86) | Aromatase inhibitors (AIs)c | 52.9 (55) |
None | 17.3 (18) | Radiotherapy | |
Educational level | Yes | 71.2 (74) | |
Primary or secondary school | 33.7 (35) | No | 28.8 (30) |
High school | 32.7 (34) | Chemotherapy | |
College or above | 33.7 (35) | Yes | 61.5 (64) |
Socioeconomic status | No | 38.5 (40) | |
Low | 17.3 (18) | Pathological tumor stage | |
Middle | 70.2 (73) | T1 | 40.4 (42) |
High | 12.5 (13) | T2 | 51 (53) |
Body mass index (kg/m2) | T3 | 8.7 (9) | |
≤ 24.9 | 31.7 (33) | Histological grade | |
25–29.9 | 40.4 (42) | Grade I | 11.5 (12) |
≥30 | 27.9 (29) | Grade II | 49 (51) |
Menopausal status | Grade III | 39.4 (41) | |
Pre-menopausal | 46.2 (48) | Type of surgery | |
Peri or post-menopausal | 53.8 (56) | Mastectomy | 56.7 (59) |
Breast conserving surgery | 43.3 (45) |